Co-Diagnostics, Inc. Gain (Loss) on Sale of Other Investments
Co-Diagnostics, Inc. (CODX) reported Gain (Loss) on Sale of Other Investments of $748.56 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:GainLossOnSaleOfOtherInvestments · last filed 2020-11-16
- Co-Diagnostics, Inc. gain (loss) on sale of other investments for the quarter ending 2020-09-30 was $748.56K.
- Co-Diagnostics, Inc. gain (loss) on sale of other investments for the quarter ending 2020-06-30 was $258.56K, a 14862.91% increase year-over-year.
- Co-Diagnostics, Inc. gain (loss) on sale of other investments for the quarter ending 2020-03-31 was $9.18K.
- Co-Diagnostics, Inc. gain (loss) on sale of other investments for the quarter ending 2019-12-31 was -$116.00K.
- Co-Diagnostics, Inc. gain (loss) on sale of other investments for fiscal 2019 was -$232.88K.
- Co-Diagnostics, Inc. gain (loss) on sale of other investments for fiscal 2018 was -$38.76K.
- Co-Diagnostics, Inc. gain (loss) on sale of other investments for fiscal 2017 was -$16.40K.
| Period end | Gain (Loss) on Sale of Other Investments 3 month | Gain (Loss) on Sale of Other Investments 6 month | Gain (Loss) on Sale of Other Investments 9 month | Gain (Loss) on Sale of Other Investments 12 month |
|---|---|---|---|---|
| 2020-09-30 | $748.56K 10-Q · filed 2020-11-16 | $1.01M derived: sum of 2 quarters · filed 2020-11-16 | $1.02M 10-Q · filed 2020-11-16 | $900.29K derived: sum of 4 quarters · filed 2020-11-16 |
| 2020-06-30 | $258.56K 10-Q/A · filed 2020-11-03 | $267.74K 10-Q/A · filed 2020-11-03 | $151.74K derived: sum of 3 quarters · filed 2020-11-03 | $41.86K derived: sum of 4 quarters · filed 2020-11-16 |
| 2020-03-31 | $9.18K 10-Q · filed 2020-05-14 | -$106.82K derived: sum of 2 quarters · filed 2020-05-14 | -$216.70K derived: sum of 3 quarters · filed 2020-11-16 | -$214.97K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-12-31 | -$116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$225.88K derived: sum of 2 quarters · filed 2020-11-16 | -$224.15K derived: sum of 3 quarters · filed 2020-11-16 | -$232.88K 10-K · filed 2020-03-30 |
| 2019-09-30 | -$109.88K 10-Q · filed 2020-11-16 | -$108.15K derived: sum of 2 quarters · filed 2020-11-16 | -$116.88K 10-Q · filed 2020-11-16 | -$158.15K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $1.73K 10-Q/A · filed 2020-11-03 | -$7.00K 10-Q/A · filed 2020-11-03 | -$48.27K derived: sum of 3 quarters · filed 2020-11-03 | $19.69K derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-03-31 | -$8.73K 10-Q · filed 2020-05-14 | -$50.00K derived: sum of 2 quarters · filed 2020-05-14 | $17.96K derived: sum of 3 quarters · filed 2020-05-14 | -$7.13K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$41.27K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $26.69K derived: sum of 2 quarters · filed 2020-03-30 | $1.60K derived: sum of 3 quarters · filed 2020-03-30 | -$38.76K 10-K · filed 2020-03-30 |
| 2018-09-30 | $67.96K 10-Q · filed 2019-11-12 | $42.87K derived: sum of 2 quarters · filed 2019-11-12 | $2.51K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$25.09K 10-Q · filed 2019-08-14 | -$65.45K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | -$40.36K 10-Q · filed 2019-05-14 | |||
| 2017-12-31 | -$16.40K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |